These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35774685)

  • 1. A Rare Case of Metachronous Quadruple Primary Malignancies in a Single Patient: A Case Report and Comprehensive Literature Review.
    Raikar M; Mandal S; Manas F; Kolade VO
    Cureus; 2022 May; 14(5):e25405. PubMed ID: 35774685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
    Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
    BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between the ALK Gene Status and the Efficacy of First-line 
Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma].
    Chen M; Cao H; Ji Y; Mao Y; Shen S; Li X
    Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):732-736. PubMed ID: 29167001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype.
    Pandey RK; Shukla S; Husain N; Islam MH; Hadi R; Kant Tripathi S; Singhal A
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):131-142. PubMed ID: 35092381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].
    Lin YP; Li Q; Ma LY; Liu X; Dai M; Wang XX; Li HS; Liu JX; Shen ZH; Guo YJ; Du YX; Yang RJ; Huang YC; Zhou YC
    Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):735-740. PubMed ID: 32988155
    [No Abstract]   [Full Text] [Related]  

  • 6. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.
    Tanaka K; Hida T; Oya Y; Yoshida T; Shimizu J; Mizuno T; Kuroda H; Sakakura N; Yoshimura K; Horio Y; Sakao Y; Yatabe Y
    Cancer; 2017 May; 123(10):1731-1740. PubMed ID: 28177518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
    Dudnik E; Moskovitz M; Rottenberg Y; Lobachov A; Mandelboim R; Shochat T; Urban D; Wollner M; Nechushtan H; Rotem O; Zer A; Daher S; Bar J;
    Oncoimmunology; 2021 Jan; 10(1):1865653. PubMed ID: 33552685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pembrolizumab plus platinum-based chemotherapy for unfavorable cancer of unknown primary site: Case report.
    Kamada T; Ishiguro H; Okada S; Takeuchi H; Takahashi J; Nakashima K; Nakaseko Y; Suzuki N; Ohdaira H; Suzuki Y
    Ann Med Surg (Lond); 2020 Dec; 60():31-35. PubMed ID: 33101670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
    Chen YF; Hsieh MS; Wu SG; Chang YL; Yu CJ; Yang JC; Yang PC; Shih JY
    J Thorac Oncol; 2016 Jul; 11(7):1140-52. PubMed ID: 27094798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma.
    Zhao M; Zhan C; Li M; Yang X; Yang X; Zhang Y; Lin M; Xia Y; Feng M; Wang Q
    J Thorac Dis; 2018 Jan; 10(1):398-407. PubMed ID: 29600072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multiple Primary Malignancy Patient With FANCA Gene Mutation: A Case Report and Literature Review.
    Xia Q; Zhao LY; Yan YD; Liao Y; Di YS; Xiao XY
    Front Oncol; 2020; 10():1199. PubMed ID: 32850347
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements.
    Park S; Park TS; Choi CM; Lee DH; Kim SW; Lee JS; Kim WS; Song JS; Lee JC
    Clin Lung Cancer; 2015 Sep; 16(5):e83-9. PubMed ID: 25682546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling.
    Chaft JE; Arcila ME; Paik PK; Lau C; Riely GJ; Pietanza MC; Zakowski MF; Rusch V; Sima CS; Ladanyi M; Kris MG
    Mol Cancer Ther; 2012 Feb; 11(2):485-91. PubMed ID: 22135231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients.
    Yang J; Li H; Li B; Li W; Guo Q; Hu L; Song Z; Zhou B
    Front Oncol; 2021; 11():647598. PubMed ID: 33898318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations in non-small cell lung carcinomas of the young.
    VandenBussche CJ; Illei PB; Lin MT; Ettinger DS; Maleki Z
    Hum Pathol; 2014 Dec; 45(12):2379-87. PubMed ID: 25288236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular typing of lung adenocarcinoma with computed tomography and CT image-based radiomics: a narrative review of research progress and prospects.
    Ma JW; Li M
    Transl Cancer Res; 2021 Sep; 10(9):4217-4231. PubMed ID: 35116717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the lung with concomitant ALK fusion gene and EGFR gene mutation: A case report and literature review.
    Fan T; Song YJ; Liu XL
    Mol Clin Oncol; 2016 Feb; 4(2):203-205. PubMed ID: 26893862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Clinical Characteristics and Driver Genes in 405 Patients with Lung Cancer Complicated with Tuberculosis].
    Hu Y; Yang X; Nie L; Zhao D; An J; Li B
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):337-342. PubMed ID: 32336065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful first-line treatment of simultaneous multiple primary malignancies of lung adenocarcinoma and renal clear cell carcinoma: A case report.
    Ye X; Liu X; Yin N; Song W; Lu J; Yang Y; Chen X
    Front Immunol; 2022; 13():956519. PubMed ID: 35979370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.
    Shea M; Costa DB; Rangachari D
    Ther Adv Respir Dis; 2016 Apr; 10(2):113-29. PubMed ID: 26620497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.